We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Researchers say device developed in London could help thousands suffering from vascular disease
Neuroscience breakthrough demonstrates ability of human organoids to adopt functions of host’s visual cortex
UK biotech racing to keep antibody up to date with latest variants
Short-termism and suspicion in parts of government risk our valuable future in precision medicine
Future of pandemic less predictable than at the outset because of new variants, says Jenny Harries
For all its landmark status, lecanemab may end up representing a triumph of hope over evidence
Beijing accuses countries of ‘political manipulation’ for introducing testing requirements during exit wave
Also in this edition: eurozone unemployment falls to new low, uproar in Brazil and Rolls-Royce hits sales record
Bid to extend tech throughout city state to wipe out disease-carrying mosquito population
Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS
A surge in cases after China lifted restrictions has sparked concerns that a dangerous new strain could emerge
Ministers want to supercharge the £89bn life science industry. But it will take long-term thinking on investment, talent and infrastructure
Global health body issues its strongest rebuke yet of Beijing’s handling of the pandemic
China’s unleashing of the virus is raising questions about the potential for harmful, new variants
Chinese authorities will expect big banks to support struggling enterprises with soft loans and outright rescues
Lockdowns have often been more relentless in rural areas, upending the education of millions and blocking social mobility
Success in battle against Covid does not ensure success against tumours, but should narrow the odds
Beijing’s war games with Russia and aggression against Taiwan fail to distract from public health crisis
Programmes involving millions of volunteers will cement Britain’s place as leader in DNA research
Move comes as US, Japan and India introduce tests and EU debates issue with Italy
France, Germany and other states say situation does not warrant change in coronavirus policies
There are echoes of early 2020 in Xi’s policy of obfuscation
Territory drops mandatory testing for arrivals as it follows Beijing’s exit from virus controls
Forced to abandon its draconian policy, Beijing’s unconvincing narrative cannot hide its lack of preparation
Eli Lilly, Amgen, Pfizer and Regeneron follow Novo Nordisk into obesity treatments worth billions
International Edition
